Forte Biosciences, Inc.
Nasdaq: FBRXPharmaceutical Preparations · Entity-resolved by Clous
CIK0001419041
TickerFBRX
ExchangeNasdaq
SIC2834
StateDE
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
Revenue
—
—
Net IncomeFY2025-12-31
-$69.38M
-95.5% YoY
Total AssetsFY2025-12-31
$82.78M
+34.5% YoY
EquityFY2025-12-31
$60.99M
+16.2% YoY
Shares OutstandingFY2025-12-31
13.89M
—
Operating Cash FlowFY2025-12-31
-$50.88M
-65.5% YoY
Market
Market
FBRXClose price
$17.87
Market cap
$248.14M
delayed EOD · as of 2026-06-18
Short interest & fails
Short-sale volume
FINRA Reg SHO · daily45.3%
short of total volume · 2026-06-18
2026-06-1845.3%
2026-06-1760.2%
2026-06-1674.0%
2026-06-1566.7%
2026-06-1226.4%
Fails-to-deliver
SEC CNS fails · semi-monthly99
shares failed · 2026-05-21
2026-05-2199 sh$20.31
2026-05-2099 sh$20.07
2026-05-1999 sh$20.97
2026-05-131.14K sh$24.29
2026-05-06150 sh$27.29
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Net Income | -$13.88M | -$31.48M | -$35.48M | -$69.38M | -95.5% | — |
| Total Assets | $42M | $38.98M | $61.56M | $82.78M | +34.5% | — |
| Equity | $38.82M | $35.31M | $52.48M | $60.99M | +16.2% | — |
| Operating Cash Flow | -$8.19M | -$28.71M | -$30.75M | -$50.88M | -65.5% | — |
| Shares Outstanding | — | — | — | 13.89M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001419041